- AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- AVROBIO Provides Regulatory Update on Investigational AVR-RD-01 for Fabry Disease
- AVROBIO to Present Clinical and Preclinical Data at the ASGCT 24th Annual Meeting
- AVROBIO Reports Fourth Quarter and Fiscal Year 2020 Financial Results and Provides Business Update
- AVROBIO Receives Orphan Drug Designation from the European Commission for AVR‑RD‑04, an Investigational Gene Therapy for Cystinosis
- AVROBIO to Present at Three Upcoming Investor Conferences in March
AVROBIO Inc (AVRO:NSQ) closed at 8.60, 6.83% above its 52-week low of 8.05, set on May 07, 2021.
8.05May 07 202123.50Jun 10 2020
Markit short selling activity
|Market cap||357.95m USD|
|EPS (TTM)||-3.31 |
Data delayed at least 15 minutes, as of May 07 2021 21:00 BST.